BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 25766041)

  • 1. Adherence to evidence-based secondary prevention pharmacotherapy in patients after an acute coronary syndrome: A systematic review.
    Chen HY; Saczynski JS; Lapane KL; Kiefe CI; Goldberg RJ
    Heart Lung; 2015; 44(4):299-308. PubMed ID: 25766041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patients' adherence to secondary prevention pharmacotherapy after acute coronary syndromes.
    Kassab Y; Hassan Y; Abd Aziz N; Ismail O; AbdulRazzaq H
    Int J Clin Pharm; 2013 Apr; 35(2):275-80. PubMed ID: 23283596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age-related differences in factors associated with the underuse of recommended medications in acute coronary syndrome patients at least one year after hospital discharge.
    Jin H; Tang C; Wei Q; Chen L; Sun Q; Ma G; Liu N
    BMC Cardiovasc Disord; 2014 Sep; 14():127. PubMed ID: 25252927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utilization of Evidence-Based Secondary Prevention Medications at the Time of Discharge in Patients with Acute Coronary Syndrome (ACS) in Qatar.
    El-Hajj MS; Saad A; Al-Suwaidi J; Al-Marridi WZ; Elkhalifa DH; Mohamed AA; Mahfoud ZR
    Curr Vasc Pharmacol; 2016; 14(4):394-403. PubMed ID: 26916397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of a reminder system using an automated short message service on medication adherence following acute coronary syndrome.
    Khonsari S; Subramanian P; Chinna K; Latif LA; Ling LW; Gholami O
    Eur J Cardiovasc Nurs; 2015 Apr; 14(2):170-9. PubMed ID: 24491349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of discharge education strategies versus usual care on clinical outcomes in acute coronary syndrome patients: a systematic review.
    Kourbelis CM; Marin TS; Foote J; Brown A; Daniel M; Coffee NT; Newman P; Beks H; Ganesan A; Versace VL; Nicholls S; Clark RA
    JBI Evid Synth; 2020 Feb; 18(2):309-331. PubMed ID: 32229737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimizing prevention and guideline-concordant care in Montenegro.
    Knežević B; Musić L; Batrićević G; Bošković A; Bulatović N; Nenezić A; Vujović J; Kalezić M
    Int J Cardiol; 2016 Aug; 217 Suppl():S32-6. PubMed ID: 27381861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient Adherence to Secondary Prevention Therapies After an Acute Coronary Syndrome: A Scoping Review.
    Bahit MC; Korjian S; Daaboul Y; Baron S; Bhatt DL; Kalayci A; Chi G; Nara P; Shaunik A; Gibson CM
    Clin Ther; 2023 Nov; 45(11):1119-1126. PubMed ID: 37690915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving patient adherence to secondary prevention medications 6 months after an acute coronary syndrome: observational cohort study.
    Brieger D; Chow C; Gullick J; Hyun K; D'Souza M; Briffa T;
    Intern Med J; 2018 May; 48(5):541-549. PubMed ID: 29345403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of pharmacist care on medication adherence and cardiovascular outcomes among patients post-acute coronary syndrome: A systematic review.
    El Hajj MS; Jaam MJ; Awaisu A
    Res Social Adm Pharm; 2018 Jun; 14(6):507-520. PubMed ID: 28641999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identifying psychosocial predictors of medication non-adherence following acute coronary syndrome: A systematic review and meta-analysis.
    Crawshaw J; Auyeung V; Norton S; Weinman J
    J Psychosom Res; 2016 Nov; 90():10-32. PubMed ID: 27772555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multifaceted intervention to improve medication adherence and secondary prevention measures after acute coronary syndrome hospital discharge: a randomized clinical trial.
    Ho PM; Lambert-Kerzner A; Carey EP; Fahdi IE; Bryson CL; Melnyk SD; Bosworth HB; Radcliff T; Davis R; Mun H; Weaver J; Barnett C; Barón A; Del Giacco EJ
    JAMA Intern Med; 2014 Feb; 174(2):186-93. PubMed ID: 24247275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intentional and unintentional non-adherence to medications following an acute coronary syndrome: a longitudinal study.
    Molloy GJ; Messerli-Bürgy N; Hutton G; Wikman A; Perkins-Porras L; Steptoe A
    J Psychosom Res; 2014 May; 76(5):430-2. PubMed ID: 24745787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of evidence-based therapy for the secondary prevention of acute coronary syndromes in Malaysian practice.
    Kassab YW; Hassan Y; Aziz NA; Akram H; Ismail O
    J Eval Clin Pract; 2013 Aug; 19(4):658-63. PubMed ID: 22845427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TEXT messages to improve MEDication adherence and Secondary prevention (TEXTMEDS) after acute coronary syndrome: a randomised clinical trial protocol.
    Chow CK; Thiagalingam A; Santo K; Kok C; Thakkar J; Stepien S; Billot L; Jan S; Joshi R; Hillis GS; Brieger D; Chew DP; Rådholm K; Atherton JJ; Bhindi R; Collins N; Coverdale S; Hamilton-Craig C; Kangaharan N; Maiorana A; McGrady M; Shetty P; Thompson P; Rogers A; Redfern J
    BMJ Open; 2018 Jan; 8(1):e019463. PubMed ID: 29374674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Timing of First Postdischarge Follow-up and Medication Adherence After Acute Myocardial Infarction.
    Faridi KF; Peterson ED; McCoy LA; Thomas L; Enriquez J; Wang TY
    JAMA Cardiol; 2016 May; 1(2):147-55. PubMed ID: 27437885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of pharmacist-initiated interventions in improving acute coronary syndrome secondary prevention pharmacotherapy prescribing upon discharge.
    Hassan Y; Kassab Y; Abd Aziz N; Akram H; Ismail O
    J Clin Pharm Ther; 2013 Apr; 38(2):97-100. PubMed ID: 23441979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of preventive cardiovascular pharmacotherapy after coronary artery bypass graft surgery.
    Barry AR; Koshman SL; Norris CM; Ross DB; Pearson GJ
    Pharmacotherapy; 2014 May; 34(5):464-72. PubMed ID: 24877186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secondary preventive medication use in a prevalent population-based cohort of acute coronary syndrome survivors.
    Gunnell AS; Hung J; Knuiman MW; Nedkoff L; Gillies M; Geelhoed E; Hobbs MS; Katzenellenbogen JM; Rankin JM; Ortiz M; Briffa TG; Sanfilippo FM
    Cardiovasc Ther; 2016 Dec; 34(6):423-430. PubMed ID: 27489053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving the Prescribing Gap For Guideline Recommended Medications Post Myocardial Infarction.
    Wilkins B; Hullikunte S; Simmonds M; Sasse A; Larsen P; Harding SA
    Heart Lung Circ; 2019 Feb; 28(2):257-262. PubMed ID: 29523466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.